Ireland· IE-PA-PPA0465/515/001
Alvesco 160 microgram pressurised inhalation, solution
A ciclesonide product containing ciclesonide, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ciclesonide is registered in 15 of 19 countries.
Countries holding a registration under ATC R03BA08 (ciclesonide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Ciclesonide · ATC R03BA08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Ciclesonide
- Manufacturer
- PCO Manufacturing Ltd.
- Country
- Ireland (IE)
- ATC code
- R03BA08
- ATC class
- Ciclesonide
- Defined daily dose
- 0.16 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA0465/515/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
77 interactions on record for ciclesonide.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ciclesonide · interactions on record
77 records
- 5 severe
- 42 moderate
- 19 minor
- 11 info
Most severe, free to view
- DesmopressinH01BA02severe
- CladribineL01BB04severe
- Dinutuximab betaL01FX06severe
- Brexucabtagene autoleucelL01XL06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ciclesonide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALVESCOCovis Pharma Europe B.V., Amsterdam
- United KingdomAlvesco 160 inhalerNecessity Supplies Ltd
- FinlandAlvescoCOVIS PHARMA EUROPE B.V.
- PolandAlvesco 160InPharm Sp. z o.o.
- SpainALVESCO 160 microgramos/INHALACION SOLUCION PARA INHALACION EN ENVASE A PRESIONCovis Pharma Europe B.V.
- United StatesAlvescoCovis Pharma US, Inc
- BelgiumAlvesco 160 µgTakeda Belgium
- NetherlandsAlvesco 160 Inhalator, aërosol, oplossing 160 microgram/dosisAzurity Pharmaceuticals Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Alvesco, Ciclesonid Genetic
- Bulgaria · Alvesco, Алвеско
- Cyprus · Alvesco
- Czechia · Alvesco, Ciclesonide Glenmark
- Germany · Alvesco, Ciclesonid Glenmark
- Denmark · Alvesco, Ciclasonide Glenmark
- Spain · Alvesco
- Finland · Alvesco, Ciclesonide Glenmark
- France · Alvesco
- United Kingdom (Northern Ireland) · Alvesco, Ciclesonide Advanz Pharma
- Greece · Alvesco, Ciclair
- Croatia · Airclesio, Alvesco
- Hungary · Alvesco, Ciclesonid Sandoz
- Italy · Airven, Alvesco
- Latvia · Alvesco
- Netherlands · Alvesco Inhalator, Ciclesonide Ace
- Norway · Alvesco, Ciclesonide Glenmark
- Poland · Alvesco, Cyxezon
- Romania · Alvesco Inhaler
- Sweden · Alvesco, Ciclesonide Glenmark
- Slovenia · Alvesco, Cmykle
- Slovakia · Airclesio, Alvesco
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e92916ee-144b-4b5c-b6e9-362cfb257f10 GET /v1/drugs/e92916ee-144b-4b5c-b6e9-362cfb257f10?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pressurised inhalation, solution",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"R03BA08"
],
"strength": null,
"pa_number": "PPA0465/515/001",
"substances": [
"Ciclesonide"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "04/04/2025",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ciclesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.